Vivanza Biosciences consolidated net profit declines 54.35% in the December 2023 quarter

Sales rise 11.95% to Rs 6.56 crore

Net profit of Vivanza Biosciences declined 54.35% to Rs 0.21 crore in the quarter ended December 2023 as against Rs 0.46 crore during the previous quarter ended December 2022. Sales rose 11.95% to Rs 6.56 crore in the quarter ended December 2023 as against Rs 5.86 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales6.565.86 12 OPM %4.429.56 -PBDT0.210.46 -54 PBT0.210.46 -54 NP0.210.46 -54

Powered by Capital Market - Live News